Citi analyst Joanne Wuensch upgraded Medtronic (MDT) to Buy from Neutral with a price target of $107, up from $92. The stock initially fell 7% ...
In the fourth episode of The Deep End, Jon Nelson and others describe dealing with emotions they haven’t felt in a long time.
The University of California, San Diego (UCSD) has initiated a clinical trial to assess Nexalin Technology's Halo Clarity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback